Pages that link to "Q36203102"
Jump to navigation
Jump to search
The following pages link to Anemia and heart failure (Q36203102):
Displayed 9 items.
- Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). (Q36623051) (← links)
- Approaches to the treatment of anaemia in patients with chronic heart failure (Q37130139) (← links)
- Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial (Q37276822) (← links)
- Use of erythropoiesis-stimulating agents in the treatment of anemia in patients with systolic heart failure (Q38226494) (← links)
- Management of Anemia and Iron Deficiency in Heart Failure (Q42824239) (← links)
- Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support (Q43269512) (← links)
- Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial (Q50602023) (← links)
- T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF (Q90548908) (← links)
- Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week (Q98174765) (← links)